Robert E. Kalb

1.0k total citations
18 papers, 686 citations indexed

About

Robert E. Kalb is a scholar working on Immunology, Dermatology and Economics and Econometrics. According to data from OpenAlex, Robert E. Kalb has authored 18 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Dermatology and 4 papers in Economics and Econometrics. Recurrent topics in Robert E. Kalb's work include Psoriasis: Treatment and Pathogenesis (15 papers), Dermatology and Skin Diseases (8 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Robert E. Kalb is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (15 papers), Dermatology and Skin Diseases (8 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Robert E. Kalb collaborates with scholars based in United States, United Kingdom and Denmark. Robert E. Kalb's co-authors include Mark Lebwohl, Marc Chévrier, Stephen Calabro, Arnon D. Cohen, Wayne Langholff, Yin You, Kavitha Goyal, Craig L. Leonardi, John Toole and Steven Fakharzadeh and has published in prestigious journals such as Journal of the American Academy of Dermatology, Journal of the European Academy of Dermatology and Venereology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Robert E. Kalb

18 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Kalb United States 10 546 337 115 102 89 18 686
Michael Bukhalo United States 10 518 0.9× 361 1.1× 79 0.7× 88 0.9× 90 1.0× 18 668
J.M. Carrascosa Spain 15 400 0.7× 201 0.6× 121 1.1× 93 0.9× 88 1.0× 32 571
M. Sánchez‐Regaña Spain 17 471 0.9× 401 1.2× 82 0.7× 159 1.6× 186 2.1× 43 684
X. Bordas Spain 17 594 1.1× 356 1.1× 176 1.5× 133 1.3× 183 2.1× 33 934
A.L.A. Kuijpers Netherlands 16 482 0.9× 241 0.7× 119 1.0× 124 1.2× 80 0.9× 23 710
Kavitha Goyal United States 12 828 1.5× 389 1.2× 204 1.8× 130 1.3× 114 1.3× 22 1.0k
Wendell C. Valdecantos United States 17 503 0.9× 386 1.1× 101 0.9× 75 0.7× 76 0.9× 32 618
M. Milutinovic Switzerland 7 965 1.8× 637 1.9× 197 1.7× 217 2.1× 62 0.7× 12 1.0k
R.J.B. Driessen Netherlands 21 760 1.4× 522 1.5× 186 1.6× 104 1.0× 74 0.8× 40 1.0k
Eva Vilarrasa Spain 20 545 1.0× 610 1.8× 121 1.1× 116 1.1× 219 2.5× 50 967

Countries citing papers authored by Robert E. Kalb

Since Specialization
Citations

This map shows the geographic impact of Robert E. Kalb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Kalb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Kalb more than expected).

Fields of papers citing papers by Robert E. Kalb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Kalb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Kalb. The network helps show where Robert E. Kalb may publish in the future.

Co-authorship network of co-authors of Robert E. Kalb

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Kalb. A scholar is included among the top collaborators of Robert E. Kalb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Kalb. Robert E. Kalb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lockshin, Benjamin, Joseph F. Merola, Ken Gordon, et al.. (2024). The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. Dermatology and Therapy. 14(2). 323–339. 4 indexed citations
2.
Kalb, Robert E., et al.. (2020). Optimizing the Treatment of Moderate-to-Severe Psoriasis in Older Adults. Drugs & Aging. 37(10). 715–723. 7 indexed citations
3.
Cohen, Arnon D., Ronald Vender, Luigi Naldi, et al.. (2020). Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council. JAAD International. 1(2). 224–230. 8 indexed citations
4.
Griffiths, C.E.M., Linda Stein Gold, F. Cambazard, et al.. (2018). Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study. European Journal of Dermatology. 28(3). 356–363. 25 indexed citations
5.
Paul, C., Linda Stein Gold, F. Cambazard, et al.. (2016). Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO‐ABLE study. Journal of the European Academy of Dermatology and Venereology. 31(1). 119–126. 93 indexed citations
6.
Kalb, Robert E., David Fiorentino, Mark Lebwohl, et al.. (2015). Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis. JAMA Dermatology. 151(9). 961–961. 266 indexed citations
7.
Lebwohl, Mark, Arthur Kavanaugh, April W. Armstrong, Abby S. Van Voorhees, & Robert E. Kalb. (2014). Patient Perspectives on Psoriasis Management: U.S. Results of the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. 20a(4). 124–131. 3 indexed citations
8.
Kalb, Robert E., Andrew Blauvelt, Howard Sofen, et al.. (2013). Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.. PubMed. 12(8). 874–80. 20 indexed citations
9.
Gottlieb, Alice B., Robert E. Kalb, Andrew Blauvelt, et al.. (2011). The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study. Journal of the American Academy of Dermatology. 67(4). 642–650. 45 indexed citations
10.
Pootrakul, Llana & Robert E. Kalb. (2010). The management of psoriasis in children and adolescents.. PubMed. 145(2). 259–68. 4 indexed citations
11.
Voorhees, Abby S. Van, Bruce F. Bebo, Dafna D. Gladman, et al.. (2009). Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 62(2). 291–299. 89 indexed citations
12.
Sobell, Jeffrey M., Robert E. Kalb, & Jeffrey M Weinberg. (2009). Management of moderate to severe plaque psoriasis (part 2): clinical update on T-cell modulators and investigational agents.. PubMed. 8(3). 230–8. 8 indexed citations
13.
Kalb, Robert E., Jerry Bagel, Neil J. Korman, et al.. (2008). Treatment of intertriginous psoriasis: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 60(1). 120–124. 54 indexed citations
14.
Kalb, Robert E., et al.. (2008). Systemic therapy for psoriasis.. PubMed. 20(2). 105–11; quiz 112. 3 indexed citations
15.
Kalb, Robert E., et al.. (2005). Infliximab for the treatment of psoriasis: Clinical experience at the State University of New York at Buffalo. Journal of the American Academy of Dermatology. 53(4). 616–622. 18 indexed citations
16.
Bernhard, Jeffrey D., Claire Whitmore, Cynthia Guzzo, et al.. (1991). Evaluation of halobetasol propionate ointment in the treatment of plaque psoriasis: Report on two double-blind, vehicle-controlled studies. Journal of the American Academy of Dermatology. 25(6). 1170–1174. 26 indexed citations
17.
Watson, William A., et al.. (1990). The Safety of Halobetasol 0.05% Ointment in the Treatment of Psoriasis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(2). 107–111. 10 indexed citations
18.
Kalb, Robert E., et al.. (1990). Follicular purpuric macules of the extremities. Scurvy.. PubMed. 126(3). 385–6, 388. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Bukhalo Breakdown of academic impact, for papers by J.M. Carrascosa Breakdown of academic impact, for papers by M. Sánchez‐Regaña Breakdown of academic impact, for papers by X. Bordas Breakdown of academic impact, for papers by A.L.A. Kuijpers Breakdown of academic impact, for papers by Kavitha Goyal Breakdown of academic impact, for papers by Wendell C. Valdecantos Breakdown of academic impact, for papers by M. Milutinovic Breakdown of academic impact, for papers by R.J.B. Driessen Breakdown of academic impact, for papers by Eva Vilarrasa
Rankless by CCL
2026